Regeneron Wants COVID-19 Tech Patent Suit Axed
Regeneron Pharmaceuticals Inc. wants a New York federal judge to toss a suit claiming it used poached technology in its development and testing of COVID-19 vaccines and treatments, saying the company...To view the full article, register now.
Already a subscriber? Click here to view full article